David M. Frim to Corpus Striatum
This is a "connection" page, showing publications David M. Frim has written about Corpus Striatum.
Connection Strength
0.688
-
Implanted NGF-producing fibroblasts induce catalase and modify ATP levels but do not affect glutamate receptor binding or NMDA receptor expression in the rat striatum. Exp Neurol. 1994 Aug; 128(2):172-80.
Score: 0.119
-
Striatal degeneration induced by mitochondrial blockade is prevented by biologically delivered NGF. J Neurosci Res. 1993 Jul 01; 35(4):452-8.
Score: 0.110
-
NGF reduces striatal excitotoxic neuronal loss without affecting concurrent neuronal stress. Neuroreport. 1993 Jun; 4(6):655-8.
Score: 0.110
-
Effects of biologically delivered NGF, BDNF and bFGF on striatal excitotoxic lesions. Neuroreport. 1993 Apr; 4(4):367-70.
Score: 0.109
-
Neuroprotective effect of the surfactant poloxamer 188 in a model of intracranial hemorrhage in rats. J Neurosurg. 2007 Jan; 106(1 Suppl):36-40.
Score: 0.070
-
Poloxamer 188 volumetrically decreases neuronal loss in the rat in a time-dependent manner. Neurosurgery. 2004 Oct; 55(4):943-8; discussion 948-9.
Score: 0.060
-
Synthes Award for Resident Research in Brain and Craniofacial Injury: poloxamer 188 volumetrically decreases neuron loss in the rat model of excitotoxicity in a time-dependent manner. Clin Neurosurg. 2003; 50:374-81.
Score: 0.053
-
The effects of megadose methylprednisolone and U-78517F on toxicity mediated by glutamate receptors in the rat neostriatum. Neurosurgery. 1994 Jan; 34(1):122-7; discussion 127-8.
Score: 0.029
-
Local protective effects of nerve growth factor-secreting fibroblasts against excitotoxic lesions in the rat striatum. J Neurosurg. 1993 Feb; 78(2):267-73.
Score: 0.027